Immuno US 2024

October 2024 | San Diego, CA

Delivering advanced, commercially viable immunotherapies to meet unmet medical need

Presentation Speaker

Explore Immuno US 2024: Facilitating the Next Generation of Advanced Immunotherapies

Join a like-minded community of over 400 scientists & business leaders committed to accelerating the development & approval of advanced immunotherapies to address unmet medical needs. 

Deep-dive into the most need-to-know data, technologies and strategies in drug discovery, clinical development & manufacturing across multiple modalities, from novel cell therapies and therapeutic antibodies, to oncolytic viruses and the microbiome. From the big-picture challenges in the regulation and commercialization of these novel products through to the technical considerations affecting each stage of the development pipeline, Immuno US highlights the tools you need to fast-track your product development. Alongside presentations and panel discussions, the conference features a host of formal and informal networking opportunities allowing you to foster long-term collaborations and meet the right partners for your research goals.

Immuno US 2024

  • Gain insights into emerging immune-targeting modalities with the potential to transform patient care, including cell & gene therapies, therapeutic antibodies, vaccines & oncolytic viruses
  • Take a deep dive into translational & pre-clinical development with discussions on animal modelling techniques and screening strategies to assess safety and efficacy
  • Ensure your late stage development is set up for success. Streamline your route through the clinic with the successful implementation of effective trial design strategies, and ensure scalability of your product 

Agenda at a Glance

  • Day One, Track 1: Discovery & Validation of Novel Modalities – Cell & Gene Therapy
  • Day One, Track 2: Discovery & Validation of Novel Modalities – Microbiome & the Gut-Immune Axis
  • Day One, Track 3: Biomarkers & Multi-Omics For Precision Oncology & Immunology
  • Day One, Track 4: Designing Clinical Trials for Success
  • Day Two, Track 1: Discovery & Validation of Novel Modalities – Therapeutic Antibodies
  • Day Two, Track 2: Discovery & Validation of Novel Modalities – Oncolytic Viruses & Cancer Vaccines
  • Day Two, Track 3: Predictive Models & Tools for Preclinical Evaluation
  • Day Two, Track 4: Manufacturing Novel Products at Scale

What to Expect


leading pharma, biotech & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Immuno US 2023: 12 - 13 October 2023, San Diego, USA

Amy Rappaport
Senior Director,
Gritstone Oncology
Eric Smith
Executive Director,
Jean-Francois Martini
Executive Director, Translational Oncology Lead, Global Product Development,
Marya Chaney
Executive Director, Clinical Research,
Merck US
Peggy Thompson
Vice President Biology,
Thomas Schuerpf
Vice President, Head of Development,
Incendia Therapeutics

All Speakers

Aditya Murthy
Gilead Sciences
Alexis Combes
Assistant Professor and Director of Disease to Biology CoLab,
UC San Francisco
Angus Sinclair
Senior Vice President Immuno-oncology,
IGM Biosciences
Christine Bowman
Principal Investigator, Biology,
Arcus Biosciences
Courtney Beers
Chief Scientific Officer,
Tizona Therapeutics
Faith Griffin
Associate Director, Translational Biomarker and Bioanalysis,
Floyd Romesberg
Hyun Yong Jin
Principal Scientist,
I-Ming Wang
Kareem Azab
Associate Professor,
University of Texas Southwestern Medical Center
Keegan Cooke
Senior Scientist,
Kelly Loyet
Distinguished Scientist,
Marilena Gallotta
Principal Scientist, Preclinical Pharmacology,
Matthew Chun
Senior Principal Scientist,
Michael Abadier
Director, Translational Medicine - Oncology,
Moderna Therapeutics
Niels Vande Casteele
Department of Medicine,
Nikos Kourtis
Principal Scientist,
Sailaja Battula
Vice-President, R&D,
Shigeki Miyake-Stoner
Head of Technology,
Replicate Bioscience
Shilpa Keerthivasan
Principal Scientist,
Bristol Myers Squibb
Sonia Feau
Director of Biology,
Onchilles Pharma Inc
Thierry Guillaudeux
Chief Scientific Officer,

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Uncovering Mechanisms of Immunotherapy Response & Resistance with Single Cell & Spatial Multiomics

Discover how 10x Genomics' spatial technologies are revolutionising the study of immunotherapies in solid tumors

Decoding the Language of Tumor Immune Microenvironment: A Deep Dive into Spatial Biology Techniques

Immuno by Oxford Global will delve into the fascinating world of spatial biology techniques and their role in decoding the language of the tumour immune microenvironment.

Spatial Transcriptomics for Immuno-Oncology and Analysis of the Tumour Microenvironment

An overview of the use of spatial transcriptomics in applications for immuno-oncology and the analysis of the tumour microenvironment.

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch